We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$203B
AUM Growth
+$28.4B
Cap. Flow
+$14B
Cap. Flow %
6.91%
Top 10 Hldgs %
26.11%
Holding
7,181
New
869
Increased
2,214
Reduced
2,337
Closed
1,192

Sector Composition

Rank Sector Weight
1 Technology 8.37%
2 Healthcare 7.45%
3 Consumer Discretionary 5.14%
4 Industrials 5.1%
5 Financials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNR
4426
PUT
Core Natural Resources Inc
CNR
$4.02B
$536K ﹤0.01%
+7,900
New +$482K
VLUE icon
4427
iShares MSCI USA Value Factor ETF
VLUE
$9.17B
$535K ﹤0.01%
+5,709
New +$520K
P
4428
CALL
Everpure Inc
P
$25.7B
$534K ﹤0.01%
+14,500
New +$411K
TWI icon
4429
Titan International
TWI
$466M
$533K ﹤0.01%
46,451
-881,452
-95% -$9.35M
ANIP icon
4430
ANI Pharmaceuticals
ANIP
$1.8B
$533K ﹤0.01%
9,906
-6,901
-41% -$306K
AQST icon
4431
Aquestive Therapeutics
AQST
$463M
$533K ﹤0.01%
322,946
+20,098
+7% +$36.4K
PSFE icon
4432
Paysafe
PSFE
$414M
$533K ﹤0.01%
52,806
-285,131
-84% -$3.61M
SMMF
4433
DELISTED
Summit Financial Group, Inc.
SMMF
$530K ﹤0.01%
25,664
-46,208
-64% -$909K
CRIS icon
4434
Curis
CRIS
$9.78M
$529K ﹤0.01%
1,592
-208
-12% -$67.7K
OFS icon
4435
OFS Capital
OFS
$45M
$527K ﹤0.01%
53,252
+18,570
+54% +$182K
DNMR
4436
DELISTED
Danimer Scientific, Inc.
DNMR
$525K ﹤0.01%
5,511
-578
-9% -$74.1K
TIPT icon
4437
Tiptree Inc
TIPT
$662M
$524K ﹤0.01%
34,924
-78,052
-69% -$1.09M
BOCN
4438
DELISTED
Blue Ocean Acquisition Corp Class A Ordinary Shares
BOCN
$523K ﹤0.01%
49,500
IMNM icon
4439
Immunome
IMNM
$2.58B
$522K ﹤0.01%
66,006
-83,644
-56% -$457K
DICE
4440
PUT
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$520K ﹤0.01%
+11,200
New +$387K
CTS icon
4441
CTS Corp
CTS
$1.83B
$520K ﹤0.01%
12,199
-6,407
-34% -$282K
CMPX icon
4442
Compass Therapeutics
CMPX
$344M
$520K ﹤0.01%
163,466
-814,937
-83% -$2.56M
CSLM
4443
DELISTED
CSLM Acquisition Corp. Class A Ordinary Share
CSLM
$519K ﹤0.01%
49,500
FSFG
4444
DELISTED
First Savings Financial Group
FSFG
$519K ﹤0.01%
39,314
-4,431
-10% -$60K
ACRS icon
4445
CALL
Aclaris Therapeutics
ACRS
$726M
$519K ﹤0.01%
50,000
NMRK icon
4446
Newmark Group
NMRK
$2.66B
$518K ﹤0.01%
83,308
-297,689
-78% -$1.83M
BKCC
4447
DELISTED
BlackRock Capital Investment Corporation
BKCC
$517K ﹤0.01%
157,679
+4,960
+3% +$16.2K
BIOX icon
4448
Bioceres Crop Solutions
BIOX
$23M
$515K ﹤0.01%
+38,558
New +$452K
ORRF icon
4449
Orrstown Financial Services
ORRF
$840M
$515K ﹤0.01%
26,887
-28,476
-51% -$529K
LIVN icon
4450
CALL
LivaNova
LIVN
$4.4B
$514K ﹤0.01%
10,000
-36,200
-78% -$1.7M

Similar funds

Millennium Management's Q2 2023 Portfolio in Review

As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.

  • Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
  • Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
  • Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
  • Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
  • Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
  • Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
  • Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.